Panel Discussion: Setting Up Context: Capitalizing on the Current Wave of Inhaled Delivery

Time: 9:00 am
day: Conference Day 1


With renewed interest sparked by COVID-19, unmet clinical needs and better formulation technologies, inhaled

delivery offers key advantages over other routes of administration for targeted local delivery. In this panel

discussion, experts will explore:

  • Reflecting on COVID-19, renewed interest and novel technologies
  • Formulating biologics for inhaled delivery such as mRNA
  • Discussing advantages of inhalation to overcome systemic toxicity issues with bypass of the liver